NCT02199145
Role of Anti-mouse PLA2R1 ELISA in Membranous Nephropathy No drug interventions basic_science Not Available completed NCT05941845
Interferon Alfa Therapy Based on Th17 Profile in Membranous Nephropathy treatment 2 not_yet_recruiting NCT06065852
National Registry of Rare Kidney Diseases No drug interventions Not Available Not Available recruiting NCT01209000
Nephrotic Syndrome Study Network No drug interventions Not Available Not Available recruiting NCT05505500
Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome. No drug interventions Not Available Not Available recruiting NCT04326218
Immunopathological Analysis in a French National Cohort of Membranous Nephropathy No drug interventions screening Not Available unknown_status NCT04571658
NEPTUNE Match Study No drug interventions Not Available Not Available enrolling_by_invitation NCT05162066
Study to Evaluate the Safety, Tolerability of BCX9930 in Participants With Either Complement 3 Glomerulopathy (C3G), Immunoglobulin A Nephropathy (IgAN), or Primary Membranous Nephropathy (PMN) No drug interventions treatment 2 terminated NCT04733040
Efficacy, Safety and PK/PD of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN) (NewPLACE) treatment 2 completed NCT06315504
Circulating Factors in Nephrotic Syndrome No drug interventions Not Available Not Available not_yet_recruiting NCT05894512
Analysis of T- and B-Cell Subpopulations in Membranous Nephropathy No drug interventions Not Available Not Available active_not_recruiting NCT03949855
Belimumab With Rituximab for Primary Membranous Nephropathy treatment 2 active_not_recruiting NCT05732402
An Open-label Study of Povetacicept (ALPN-303) in Autoimmune Kidney Diseases treatment 1 / 2 recruiting NCT01955187
Sequential Therapy With Tacrolimus and Rituximab in Primary Membranous Nephropathy treatment 3 completed NCT03929887
KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis No drug interventions Not Available Not Available recruiting NCT06341205
Personalized Rituximab Treatment Based on Artificial Intelligence in Membranous Nephropathy (iRITUX) treatment 3 not_yet_recruiting NCT05810961
A Study to Assess Effectiveness and Safety of Efgartigimod in Chinese Patients With Primary Membranous Nephropathy (ZL-1103-014) No drug interventions treatment 2 recruiting NCT03025828
Adrenocorticotropic Hormone in Membranous Nephropathy treatment 4 completed NCT04095156
Autoreactive B Cells in Membranous Nephropathy No drug interventions Not Available Not Available recruiting NCT04652570
Efficacy and Safety of VB119 in Subjects With Membranous Nephropathy treatment 1 / 2 active_not_recruiting NCT00518219
To Compare the Efficacy and Safety of Tripterygium Wilfordii (TW) Versus Valsartan in the Membranous Nephropathy (MN) treatment 4 completed NCT03453619
Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies treatment 2 completed NCT00425217
Rituximab in Membranous Nephropathy treatment 2 / 3 completed NCT00983034
The Effects of Helicobacter Pylori Eradication on Proteinuria in Patients With Membranous Nephropathy supportive_care Not Available completed NCT04893096
MOR202 for Refractory MN treatment 2 active_not_recruiting NCT05688865
Correlation and Clinical Utility of Urinary Biomarker in Membranous Glomerulonephritis No drug interventions Not Available Not Available recruiting NCT06242327
An Outcome Analysis of Primary Membranous Nephropathy No drug interventions Not Available Not Available not_yet_recruiting NCT04278729
A Prospective Multi-dose Study of Apixaban in Subjects With Nephrotic Syndrome treatment 1 completed NCT00405340
Rituximab in the Treatment of Idiopathic Membranous Nephropathy treatment 0 completed NCT05050214
Obinutuzumab in Primary MN treatment 2 active_not_recruiting NCT03880643
Rituximab in Refractory Primary Membranous Nephropathy No drug interventions Not Available Not Available completed NCT00404833
Mycophenolate Mofetil in Membranous Nephropathy and Focal Segmental treatment 3 completed NCT00135954
Treatment of Patients With Idiopathic Membranous Nephropathy treatment 3 completed NCT05797051
Application of Hyperspectral Imaging in the Diagnosis of Glomerular Diseases No drug interventions Not Available Not Available not_yet_recruiting NCT00199628
Research Network for Neonatal Diseases Induced by Tissular Fetomaternal Alloimmunization No drug interventions Not Available Not Available completed NCT00843856
Mycophenolate Mofetil and Tacrolimus Versus Tacrolimus for the Treatment of Idiopathic Membranous Glomerulonephritis treatment 4 completed NCT01762852
Efficacy and Safety Study of Intravenous Belimumab Versus Placebo in Subjects With Idiopathic Membranous Nephropathy treatment 2 withdrawn NCT05656963
The Influencing Factors and Mechanism of High Incidence of Thrombotic Events in Patients With MN and DKD No drug interventions Not Available Not Available active_not_recruiting NCT01282073
Mycophenolate Mofetil in Patients With Progressive Idiopathic Membranous Nephropathy treatment 3 unknown_status NCT05914155
Clinical Study of Rituximab for the Treatment for Idiopathic Membranous Nephropathy With Nephrotic Syndrome treatment 3 recruiting NCT03018535
Rituximab Versus Steroids and Cyclophosphamide in the Treatment of Idiopathic Membranous Nephropathy treatment 3 unknown_status NCT01129557
Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease treatment 4 terminated NCT00404794
A Study to Compare Mycophenolate Mofetil and Tacrolimus in the Treatment of Membranous Lupus Nephritis treatment 3 completed NCT01610492
A Study of Belimumab in Idiopathic Membranous Glomerulonephropathy treatment 2 completed NCT04145440
Trial to Assess Safety and Efficacy of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN) treatment 1 / 2 completed NCT00135967
Mycophenolate Mofetil in Membranous Nephropathy treatment 2 / 3 completed NCT00050713
Sirolimus Therapy for Idiopathic and Lupus Membranous Nephropathy treatment 2 completed NCT00977977
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy treatment 2 recruiting